Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.

BMC cardiovascular disorders - 8 Oct 2009

Kullmann Silke, Binner Priska, Rackebrandt Kirsten, Huge Andreas, Haltern Georg, Lankisch Mark, Füth Reiner, von Hodenberg Eberhard, Bestehorn Hans-Peter, Scheffold Thomas

Abstract excerpt

BACKGROUND: Restenosis represents the major limiting factor for the long-term efficacy of percutaneous coronary intervention (PCI). Several genetic factors involved in the regulation of the vascular system have been described to play a role in the pathogenesis of restenosis. We investigated whether the EPHX2 K55R polymorphism, previously linked to significantly higher risk for coronary heart disease (CHD), was...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angioplasty, Balloon, Coronary
Share to Calcium Channel Blockers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Coronary Angiography

Share to Coronary Disease

Share to Coronary Restenosis

Share to Epoxide Hydrolases

Share to Europe

Share to Verapamil

Source

Open in PubMed Open full text

Identifiers

PMID: 19814804
DOI: 10.1186/1471-2261-9-48
PMCID: PMC2767343

Genes

EPHX2

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.PMID 19814804Read ↗

Homozygosity for the EPHX2 K55R polymorphism increases the long-term risk of ischemic stroke in men: a study in Swedes.Semantic proximity Read ↗

Genetically reduced soluble epoxide hydrolase activity and risk of stroke and other cardiovascular disease.Semantic proximity Read ↗

Genetic risk factors and restenosis after percutaneous coronary interventions.Semantic proximity Read ↗

Toll-like receptor 4 gene polymorphisms show no association with the risk of clinical or angiographic restenosis after percutaneous coronary intervention.Semantic proximity Read ↗

Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.Semantic proximity Read ↗

Association between the EPHX2 p.Lys55Arg polymorphism and prognosis following an acute coronary syndrome.Semantic proximity Read ↗

Genetic risk markers for post-angioplasty restenosis: what should we expect?Semantic proximity Read ↗

Haplotypes of the angiotensin-converting enzyme (ACE) gene are associated with coronary artery disease but not with restenosis after coronary stenting.Semantic proximity Read ↗

Association between polymorphisms of CYP2J2 and EPHX2 genes and risk of coronary artery disease.Semantic proximity Read ↗

Matrix metalloproteinases 2 and 3 gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention: Is there still room for determining genetic variation of MMPs for assessment of an increased risk of restenosis?Semantic proximity Read ↗

Association of soluble endothelial protein C receptor plasma levels and PROCR rs867186 with cardiovascular risk factors and cardiovascular events in coronary artery disease patients: the Athero Gene study.Semantic proximity Read ↗

Apolipoprotein epsilon 4 is not a genetic risk factor for coronary artery disease or restenosis after percutaneous transluminal coronary angioplasty.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.